The Global Foundation for Peroxisomal Disorders is pleased to announce the funding of four research projects in the field of peroxisomal disorders:
Dr. Nancy Braverman of McGill University in Montreal, Canada, was awarded $10,875.00 for the Canadian arm of a project entitled “A Pilot, Mult-Center Open-Label Trial Assessing the Safety and Efficacy of Betaine in Children with Peroxisome Biogenesis Disorders.”
Dr. William Rizzo of the University of Nebraska Medical Center was awarded $25,000 for the U.S. arm of the project entitled “A Pilot, Open-Label Trial Assessing the Safety and Efficacy of Betaine in Children with Peroxisome Biogenesis Disorders.”
Dr. Joseph Hacia of the University of Southern California was awarded $50,000 for his project entitled “Neural Cell Resources for PBD-ZSD Drug Testing.”
Dr. Steven Steinberg of Kennedy Krieger Institute in Maryland was awarded $25,000 for his project entitled “Pilot Treatment of the PEX1-G844D Mouse with Diosmetin.”
Grant recipients in attendance at the 2013 GFPD Family and Scientific Conference in Lincoln, Nebraska, last month were presented with their awards at the opening ceremonies.
